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Abstract 
The human FSH receptor is a g protein-coupled receptor (GPCR) expressed on the 
surface of granulosa cells in the ovary and Sertoli cells in the testes.  FSHR has a sequence 
of amino acids consistent with a caveolin interaction motif (φXφXXXXφXXφ) found 
between amino acids 479-489 in the primary receptor sequence in the putative 4th 
transmembrane domain.  Caveolin is a protein found in cell membrane micro domains such 
as lipid rafts. These densely packed regions of the membrane are enriched for sphingolipids 
and cholesterol and are thought to be involved in signal transduction.  Caveolin can be 
found in caveolae, flask-like structures which are a specific type of lipid raft, or in non-
caveolae lipid rafts.  Although the receptor has this motif, it was unknown if hFSHR 
biochemically interacted with caveolin.  To test this hypothesis, hFSHR was isolated by 
immunoprecipitiation from HEK-293 cells stably transfected with hFSHR cDNA.  
Analysis by western blot of co-immunoprecipitated proteins revealed the presence of 
caveolin-1. Together these results suggest that caveolin-1 plays an important role in cell 
signaling by sequestering hFSHR into lipid rafts for normal receptor function.  
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Introduction 
Follicle-stimulating hormone is a hormone produced by the anterior pituitary in 
response to gonadotropin-releasing hormone, sometimes called luteinizing-hormone-
releasing hormone (LHRH). FSH targets the granulosa cells in the ovaries and the Sertoli 
cells in the testes to lead to the maturation of gametes. In males FSH promotes 
spermatogenesis in the Sertoli cells within the testes and causes the primary spermatocytes 
to undergo meiosis. In women FSH targets the granulosa cells within the ovaries to 
encourage proper development of the follicle which contains the egg to be released during 
ovulation [4]. It is for these reasons that FSH is a prime target for the development of new 
forms of birth control. 
Follicle-stimulating hormone is a glycoprotein consisting of an alpha and beta 
subunit. The alpha unit of FSH is identical to the alpha subunits of leutinizing hormone and 
thyroid stimulating hormone. It is the beta subunit that varies for each hormone and 
interacts with the receptors of that molecule [3]. In order for a molecule to be considered a 
hormone it must enter into the bloodstream and travel to its target tissue. Blood reaches 
every cell of the body. What prevents hormones from affecting every cell is the fact that a 
hormone cannot illicit a response without a receptor present. Hormones can only bind to 
their specific receptor and receptors for each hormone are only expressed in specific cells. 
A hormone is only as good as its receptor and if the receptor does not function properly the 
hormone cannot send a signal. 
Follicle stimulating hormone acts through its receptor. Human follicle stimulating 
hormone receptor is a G protein-coupled receptor occurring in the testes, ovaries, and the 
uterus. In the testes FSH binds to the Sertoli cells, causing changes that nourish the 
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developing sperm cells through the stages of spermatogenesis. FSH functions in the ovaries 
by binding to the granulosa cells and causing many changes within the developing follicle. 
If the follicular cell fails to respond to FSH then it is discarded. 
The receptor has 7 transmembrane domains that span the cell membrane in alpha 
helices. Within the 4th transmembrane domain there exists a caveolin interaction motif. The 
caveolin interaction motif is a sequence of amino acids in the alpha helix of the 
transmembrane domain. This is a sequence of amino acids ordered either φxφxxxxφ or 
φxxxxφxxφ, where φ is one of the aromatic amino acids, tryptophan, phenylalanine, or 
tyrosine, and x is any amino acid [11]. When spanning the lipid bi-layer the amino acids 
form an alpha helix with the aromatic amino acids oriented toward the outside of the helix. 
Many proteins that contain this amino acid sequence have been shown to interact directly 
with the caveolin family of proteins. Pharmacology research has shown that caveolin’s role 
in cell signaling has the potential to be manipulated to create new forms of treatment and 
therapy [8]. 
Many different types of receptors have been proven to bind with caveolin within the 
membrane. Many are signaling proteins like tyrosine kinases [2]. Several of the molecules 
proven to have this interaction are G protein coupled receptors, similar to FSHR, including 
dopamine receptor (1A), and glucagon-like peptide receptor which is involved in insulin 
secretion (Table 1). 
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Table 1. Cav-1 interacting GPCRs that contain a CIM 
Receptor CIM Sequence Transmembrane domain 
Adenosine receptor A1 228-YAFRIQKF-295 No 
D(1A) Dopamine receptor 313-FDVFVWFGW-321 Yes 
Glucagon-like peptide 1 receptor 247-EGVYLYTLLAF-257 Yes 
hFSHR 479-FAFAAALFPIF-489 Yes 
Caveolin has been found not only to interact with these receptors, but in some cases 
play an integral role in proper signaling and function [11][12][13].  
Current pharmaceutical forms of birth control function by disrupting the FSH 
pathway. Pills contain estrogen and progesterone that feed back negatively on the 
production of GnRH. Low levels of GnRH causes reduced production of FSH. Low levels 
of FSH will cause developing follicles to undergo atresia and be discarded. This greatly 
reduced the chance of ovulation and therefore pregnancy [10]. 
Disruption of the hormone cycle within the body and increasing levels of hormones 
beyond their normal levels can have some very adverse side effects. Most hormone pills 
contain a combination of estrogen and progesterone. By taking these contraceptives 
hormone levels remain high in the blood stream and are not allowed to go through the 
natural cycle which triggers ovulation. Research has suggested that prolonged exposure to 
elevated estrogen levels is linked to an increased risk of venous thromboemolism, and a 
higher risk of myocardial infarction and stroke [1]. By focusing on hFSHR’s interaction 
with caveolin instead of regulation of hormone levels these risks can be bypassed. By 
understanding how the receptor and caveolin interact we can develop new forms of birth 
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control, and fertility treatments by either increasing or disrupting signaling to the granulosa 
cells.  
FSHR and caveolin interactions could theoretically be used to develop methods of 
male birth control. While FSHR is present in many tissues within women it is less so in 
males. In men, FSHR is found primarily in the testes to promote sperm production. If this 
signaling could be disrupted than it may be possible to develop male contraceptives.  
The opposite of this is also plausible. For women or men who are having infertility 
problems related to their follicle stimulating hormone levels. By understanding the 
interactions of the receptor it may be possible to increase these reactions to promote proper 
cell function and development. New fertility drugs and treatments could be developed 
around these interactions. We believe the key to understanding FSH signaling is linked to 
caveolin and caveolae. 
 
Figure 1. Diagram illustrating lipid raft composition and caveolae. Caveolin-1 scaffolds hold the flask shape 
of the caveolae by Taken from Quest, Leyton, and Párraga  (2004). 
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Caveolin are proteins which reside in caveolae, a distinct subset of lipid rafts. Lipid 
rafts are domains of the cell membrane that are rich in cholesterol and sphingolipids which 
cause them to be densely packed and resistant to detergents. These lipid rafts act as 
signaling platforms regulating receptors and other signaling molecules. Caveolae, which is 
Latin for little caves, are flask shaped lipid rafts that are involved endocytosis and various 
signaling processes (Figure 1).   
The caveolin family of proteins, particularly caveolin-1, has been shown to have 
more important roles than just holding the shape of caveolae. Caveolae are required for 
proper signaling of some receptors [12]. Caveolin-1 also influences the protein makeup of a 
cell membrane through its interaction with receptors. Cells without caveolin-1 expression 
are often depleted of most cell surface proteins [14]. Receptors that interact with caveolin 
are dependent on caveolin to signal properly and to be sequestered into the lipid raft.  
In our research we hope to prove that human follicle-stimulating hormone receptor 
interacts with caveolin-1 within the caveolae lipid rafts. Several other studies have isolated 
GPCRs by using the same co-immunoprecipitation we have employed [12]. Some have 
even used methods to study caveolae and molecules that reside in them [7]. We will grow 
hFSHR-transfected HEK293 cells to use in the immunoprecipitation experiments. This cell 
line has already been used successfully to study the interactions of other receptors with 
caveolin [9].  We hope that by understanding more about hFSHR and its interactions that 
we will be able to use the information to develop techniques to either increase or decrease 
fertility. 
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Methods 
Optiprep gradient. Before we could begin looking for a direct interaction between 
FSHR and caveolin we needed to establish that they both occur within the same area in the 
cell membrane. By isolating the lipid raft domains of the cell membrane we could begin 
looking for these interactions. Lipid rafts can be isolated by creating a discontinuous 
gradient. 
HEK 293 cells stably transfected to express human follicle stimulating hormone 
receptor were grown to confluency in t75 flasks. The cells were then harvested and lysed 
by douncing. The lysed sample was then added to a 45 % solution of Optiprep medium in a 
centrifuged tube. This layer containing the sample was then overlaid with lower 
concentrations of Optiprep solution to create a discontinuous gradient as shown in figure 2. 
The gradient was centrifuged at 240,000 g for 18 hours. Fractions were collected starting 
from the top of the gradient and placed in microfuge tubes to isolate the buoyant lipid raft 
layer. These fractions were then separated on an SDS-PAGE gel using electrophoresis and 
probed using standard western blotting protocols. 
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Figure 2. The creation of the Optiprep gradient showing the layers of medium and the separation of lipid rafts 
from non-raft membranes 
Co-immunoprecipitation. Immunoprecipitation is a widely used method of protein 
detection and purification. An antibody specific to the target molecule is mounted on 
beaded support such as protein G sepharose. These beads are then added to a sample of 
whole cell lysate and the beads bind with the target protein. The antibody-protein complex 
is then precipitated. Any proteins not bound to an antibody are then washed away. After the 
wash all that is left is the target protein bound to the antibody. The target protein is then 
eluted from the antibody and can be analyzed by SDS-PAGE and Western blots. Co-
immunoprecipitation is done in a similar fashion except the focus is to capture not just a 
target protein but also other macromolecules that interact with it, like FSHR (Figure 3). 
Traditionally co-immunoprecipitation uses a detergent to help break up the membranes 
within the sample. Normally this would not affect protein interactions within the cytoplasm 
but the interactions that are the focus of this study occur within the membrane itself and are 
hydrophobic. The use of a detergent would destroy these interactions and make it very 
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difficult for us to study these interactions. Other researchers have demonstrated that a mild 
detergent such as octylglucoside can be used to isolate membrane receptors and their 
interacting partners [9] [11]. 
Two t75 flasks of transfected HEK293 cells were grown to confluency for each 
treatment. The cells were then washed with 5ml of ice cold 1x PBS. 5ml of ice cold 
PBS/EDTA was used to lift and harvest the cells from the flask. Cells were then transferred 
to a 15ml conical tube and centrifuged at 3000xg for five minutes at 4°C to pellet the cells. 
Supernate was removed and the cells were resuspended in 1ml of octylglucoside lysis 
buffer (10 mM Tris-Cl, pH 8, 150 mM NaCl, 60 mM octyl glucoside, 1 protease inhibitor 
pellet per 10ml). Tubes were incubated on ice for 10 minutes and were sonicated for 5 
cycles of 10 seconds each to lyse the cells. Lysate solution was then transferred to 
microfuge tube and centrifuged at max speed for 15 minutes for 15 minutes at 4°C. 
Supernate was then transferred to a new tube and 100 microliters were save for whole 
lysate controls. 5 micrograms of primary antibody were added to one tube while 5 
micrograms of IgG2B antibody were added to a second tube as a control. Samples incubated 
overnight at 4° C. 100 microliters of protein G slurry was added to each tube and allowed 
to incubate rocking end over end for 2 hours at 4° C. Beads were centrifuged for 30 
seconds at max speed at 4° C. Supernate was removed and transferred to a new tube. Beads 
were resuspended in 0.5ml of ice cold lysis buffer and centrifuged at max speed for 30 
seconds at 4° C. This wash step was repeated twice more. Beads were resuspended in 140 
microliteres of 2x sample buffer and heated to 70° C for 5 minutes. Tubes were centrifuged 
for 30 seconds at max speed at room temperature. Supernate containing purified sample 
was then placed in a new tube to be analyzed. 
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Figure 3. Process of co-immunoprecipitation by which proteins can be isolated and analyzed using an 
antibody against a specific target protein. Taken from piercenet.com 
“Good Mojo” Protocol. As we probed our western blots for caveolin and FSHR extra 
bands kept appearing in our blots. These extra bands were appearing because of the 
coupled antibodies that were still in our samples from the actual co-immunoprecipitation 
procedure. The secondary antibodies bind to any antibody already present on the blot. In 
order to see only the bands that are a result of the proteins we are looking for we use what 
we nicknamed the “good mojo” protocol. This procedure more effectively blocks the 
membrane exposing only the desired proteins. 
After transferring the sample to a membrane using standard western blot techniques 
the membrane was washed in 1x TBST. The membrane was then blocked with unlabeled 
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streptavidin in 3% BSA (100 microliters streptavidin/ 10ml 3% BSA) for one hour at room 
temperature. The membrane was then washed with 1x TBST 3 times, for 5 minutes. The 
membrane was then blocked with free biotin in 3% BSA (1 mg biotin/ 10ml 3% BSA) for 
one hour at room temperature. The membrane was then washed with 1x TBST 3 times, for 
5 minutes. The membrane was then probed with a biotinylated antibody in 3% BSA (10 
microliters antibody/ 10ml 3% BSA) overnight at 4° C. The membrane was then washed 
with 1x TBST 3 times, for 5 minutes. The membrane was then probed with streptavidin-
HRP in 3% BSA (20 microliters streptavidin-HRP/ 10ml 3% BSA) for one hour at room 
temperature. The membrane was then washed for a final time with 1x TBST 3 times, for 5 
minutes. The membrane was then developed according to standard western blot protocols. 
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Results 
To determine if follicle stimulating hormone receptor occupies the same region of 
the cell membrane a discontinuous gradient was created using HEK 293 cells transfected to 
express the receptor. The gradient was created using Optiprep and centrifuged. After the 
centrifugation there was a clearly visible layer that was composed of buoyant lipid rafts. 
Fractions were then isolated and the lipid raft fraction was captured between fractions 7 
and 9.  
When the fractions were analyzed using western blotting techniques and probed for 
FSHR and caveolin-1 it was shown that they both occupy the lipid raft domains of the cell 
(Figure 4.) 
      
Figure 4. Western blot of the fractions from the Optiprep gradient. Faction numbers are descending from top 
of column toward the bottom. Blots were probed for FSHR (top) and caveolin-1 (bottom) respectively. 
          3     4     5     6     7     8     9   10  11 
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After the results of the Optiprep gradient it was then possible to move on to co-
immunoprecipitation experiments. The first set of co-immunoprecipitations was done to 
see if we could in fact isolate the protein we were trying to precipitate, in this case follicle 
stimulating hormone receptor (Figure 5.) The sample showed that we indeed isolated 
FSHR and that none was found in the IgG2B control IP. Large amounts of receptor were 
present in the whole cell lysate. 
 
Figure 5. Early western blot showing successful immunoprecipitation of FSHR. Molecular weight markers on 
the left and whole cell lysate controls on the right. 
For the second round of co-immunoprecipitations an anti FSHR antibody was used 
to co-precipitate caveolin (Figure 6). Caveolin-1 can be seen in the whole cell lysate just 
above the 21 KD marker. However, it is difficult to identify it in any of the lanes whether 
they be control or otherwise. A large unknown band occurs in all four treatment lanes. 
27 
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184 
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WCL IgG2B 105 
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Figure 6. Western blot of samples from co-immunoprecipitation using anti-FSHR antibody. Molecular weight 
markers are shown on the left with whole lysate control on the right.  
Unable to identify caveolin in the samples, it was decided that a new method of probing was needed. 
The advantages of the good mojo protocol allow distinct bands to be seen where previously bands were 
indiscernible (Figure 7). Using the same samples as seen in figure 5 the bands that were previously hidden 
can now be seen clearly, again FSHR is not seen in the control lane. 
Another co-immunoprecipitation was done this time using an anti-caveolin-1 antibody to co-
precipitate FSHR (Figure 8). In this co-immunoprecipitation there was a hormone treatment of 30 minutes 
and a control and the samples were then co-immunoprecipitated. A band for FSHR appears in both the 
control and hormone treatment Cav1 IPs between the 85 and 52 KD markers. 
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Figure 7. Western blot using the same samples as Figure 6 to emphasize the difference between a standard 
western blot and a blot using good mojo protocol. 
 
 
Figure 8. Western blot showing the presence of FSHR from a co-immunoprecipitation experiment using an 
anti caveolin-1 antibody and probed using the good mojo protocol.  
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Discussion 
Understanding a protein’s structure and its interactions is necessary when trying to 
develop new drugs and treatments. Every piece of evidence lends itself to the larger picture 
that is molecular biology. By understanding the interactions of follicle stimulating hormone 
receptor we can create new treatments that exploit how the receptor normally functions. 
Originally we used co-immunoprecipitation with anti FSHR antibodies to search for 
caveolin, but this proved difficult and ultimately unsuccessful. The western blots were not 
clear enough to determine if caveolin was present. Our solution to this was the use of our 
good mojo protocol which uses biotinylated antibodies to produce clear western blots. 
Unfortunately we did not posses a biotinylated antibody for caveolin and were forced to do 
another round of co-immunoprecipitations this time using anti-caveolin-1 antibodies to 
isolate follicle stimulating hormone receptor. We were able to use the good mojo protocol 
to produce a western blot that clearly shows that FSHR and caveolin interact directly. 
We have shown with our Optiprep gradient that the receptor exists in lipid rafts as 
we suspected and this can allow it to signal to and interact with other proteins within and 
around the lipid raft. We have also shown that follicle stimulating hormone receptor 
interacts directly with caveolin. This means that FSHR may exist in caveolae. This 
interaction may also mean that caveolin is not only interacting with the receptor but is 
crucial for sequestering it into caveolae lipid rafts so that it can function properly. 
Ever since caveolin interaction motifs were noticed their importance in cell 
signaling has been in question. The next step is to treat with different time trials of 
hormones. For our experiments we only used two hormone treatments. Cells were treated 
either not at all or for 30 minutes with follicle stimulating hormone. It is possible that that 
 18 
there is an increase or decrease in the interaction but that our 30 minute hormone treatment 
was too long for us to clearly see the effects. Future experiments will involve timed 
treatments with FSH at increasing intervals most likely, 0 minutes, 1 minute, 5 minutes, 10 
minutes, 15 minutes, and 30 minutes. With these treatments we will be able to see if band 
intensity increases or decreases in the western blot analysis of the co-immunoprecipitation 
experiments which would correlate to an increase or decrease of interaction between the 
proteins. 
Future work will also include using cells transfected with mutant receptors that 
have an altered or are completely lacking a caveolin interaction motif. Using these 
transfected cells it can be determined whether or not the caveolin interaction motif is 
responsible for the interaction we have observed. By understanding follicle stimulating 
hormone receptor and its interactions could be the keystone in development of future forms 
of birth control and fertility treatments.  
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